Cargando…
Effects of Proton Pump Inhibitor Therapy, H. pylori Infection and Gastric Preneoplastic Pathology on Fasting Serum Gastrin Concentrations
BACKGROUND: Hypergastrinaemia occasionally indicates the presence of a gastrinoma. However it is much more commonly associated with various benign causes including proton pump inhibitor (PPI) use, Helicobacter pylori infection and/or atrophic gastritis. The extent to which these factors interact to...
Autores principales: | Veysey-Smith, Reuben, Moore, Andrew R., Murugesan, Senthil V., Tiszlavicz, Laszlo, Dockray, Graham J., Varro, Andrea, Pritchard, D. Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637328/ https://www.ncbi.nlm.nih.gov/pubmed/34867785 http://dx.doi.org/10.3389/fendo.2021.741887 |
Ejemplares similares
-
Recharacterization data for a geriatric gastrin polycolonal antibody
por: Dodd, Steven, et al.
Publicado: (2019) -
The role of plasminogen activator inhibitor-1 in gastric mucosal protection
por: Kenny, Susan, et al.
Publicado: (2013) -
Gastrin-induced miR-222 promotes gastric tumor development by suppressing p27(kip1)
por: Lloyd, Katie A., et al.
Publicado: (2016) -
Comparison of the human gastric microbiota in hypochlorhydric states arising as a result of Helicobacter pylori-induced atrophic gastritis, autoimmune atrophic gastritis and proton pump inhibitor use
por: Parsons, Bryony N., et al.
Publicado: (2017) -
The role of chemerin and ChemR23 in stimulating the invasion of squamous oesophageal cancer cells
por: Kumar, J Dinesh, et al.
Publicado: (2016)